Q1 2023 Holdings
Filed 2023-05-15 | 103 holdings | $671.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Anaptysbio Inc(ANAB) | COM | 032724106 | $44.2M | 2,032,561 | 6.6% |
| Bluebird BIO Inc | COM | 09609G100 | $31.4M | 9,882,827 | 4.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $28.1M | 1,170,000 | 4.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $27.0M | 3,197,399 | 4.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $25.6M | 2,034,158 | 3.8% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $21.5M | 135,000 | 3.2% |
| Moderna Inc(MRNA) | COM | 60770K107 | $21.0M | 136,700 | 3.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.8M | 2,651,393 | 3.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $20.1M | 405,600 | 3.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $19.7M | 320,000 | 2.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $18.3M | 85,000 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $17.6M | 692,925 | 2.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $16.2M | 300,000 | 2.4% |
| New York Cmnty Bancorp Inc(NYCBEUR) | COM | 649445103 | $14.5M | 1,606,600 | 2.2% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $14.5M | 2,520,000 | 2.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $13.3M | 1,600,000 | 2.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.8M | 170,000 | 1.8% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $11.6M | 2,750,000 | 1.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.2M | 300,000 | 1.7% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $10.5M | 321,200 | 1.6% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $10.3M | 30,000 | 1.5% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $10.0M | 2,481,662 | 1.5% |
| Zymeworks del Inc(ZYME) | COM | 98985Y108 | $9.9M | 1,100,000 | 1.5% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $9.8M | 5,300,087 | 1.5% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $9.7M | 3,624,076 | 1.4% |
| Capital One Finl Corp(COF) | COM | 14040H105 | $9.6M | 100,000 | 1.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.2M | 6,093,032 | 1.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.0M | 45,000 | 1.3% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $8.1M | 5,400,000 | 1.2% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $7.7M | 16,000 | 1.1% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $7.4M | 1,800,000 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.1M | 200,000 | 1.1% |
| Bellerophon Therapeutics Inc(BLPHUSD) | COM NEW | 078771300 | $7.1M | 893,974 | 1.1% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $6.5M | 600,000 | 1.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.3M | 1,785,829 | 0.9% |
| Comerica Inc(CMA) | COM | 200340107 | $5.8M | 133,525 | 0.9% |
| Quince Therapeutics Inc(QNCX) | COM | 22053A107 | $5.6M | 3,620,000 | 0.8% |
| Enzo Biochem Inc(ENZB) | COM | 294100102 | $5.6M | 2,300,000 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $5.1M | 500,000 | 0.8% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $5.1M | 3,399,745 | 0.8% |
| Genfit S A | ADS | 372279109 | $5.0M | 1,212,515 | 0.7% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $5.0M | 2,028,466 | 0.7% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $4.9M | 1,274,853 | 0.7% |
| Magenta Therapeutics Inc | COM | 55910K108 | $4.8M | 6,050,000 | 0.7% |
| Citigroup Inc(C) | COM NEW | 172967424 | $4.7M | 100,000 | 0.7% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $4.0M | 700,000 | 0.6% |
| First REP BK SAN Francisco C(FRCB) | COM | 33616C100 | $3.9M | 278,759 | 0.6% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.6M | 90,000 | 0.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.5M | 89,650 | 0.5% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $3.4M | 1,002,582 | 0.5% |